Nuveen Quality Municipal Income Fund (NAD) Stock Price

11.97 ▼ -0.06 (-0.50%)
Open: 11.96 Vol: 497.9K Day's range: 11.91 - 11.98 Nov 14, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
NAD Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 11.96▼ 11.96▼ 11.95▲ 12.03▼ 11.89▲
MA10 11.96▼ 11.95▲ 11.97▼ 11.97▼ 11.80▲
MA20 11.95▲ 11.98▼ 12.00▼ 11.94▲ 11.54▲
MA50 11.98▼ 12.02▼ 11.97▼ 11.82▲ 11.53▲
MA100 12.03▼ 11.96▼ 11.96▼ 11.53▲ 11.59▲
MA200 11.97▼ 11.94▲ 11.88▲ 11.49▲ 11.70▲
  5 mins 30 mins Hourly Daily Weekly
MACD 0.003▲ -0.001▼ -0.010▼ -0.003▼ 0.060▲
RSI 46.511▼ 40.668▼ 42.743▼ 54.910▲ 62.451▲
STOCH 54.762     48.525     30.128     61.289     80.513▲
WILL %R -57.143     -65.385     -65.385     -51.351     -18.447▲
CCI -16.730     -12.179     -41.991     -11.255     107.015▲
Latest Filters Detected On NAD
▼ MACD $NAD MACD(12,26,9) Crossed Below Signal Line Set Alert
MA $NAD Price Crossed Below MA(13) Set Alert
MA $NAD Price Crossed Below MA(7) Set Alert
CDL $NAD Hammer Candlestick Pattern Detected Set Alert
CDL $NAD Doji Candlestick Pattern Detected Set Alert
Nuveen Quality Municipal Income Fund News
Niagen Bioscience Launches Tru Niagen® Beauty — The First NAD+ Skincare Supplement in the U.S. Featuring Niagen® (Patented Nicotinamide Riboside)
Thursday, November 13, 2025 03:33 AM
Niagen Bioscience, Inc. (NASDAQ: NAGE), formerly ChromaDex Corp., is the global leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. As a trusted pioneer of NAD+ ...
ChromaDex Reports Record Growth Amid Strategic Expansions
Wednesday, November 05, 2025 04:21 PM
ChromaDex Corporation (($NAGE)) has held its Q3 earnings call. Read on for the main highlights of the call. The recent earnings call for ChromaDex ...
Niagen Bioscience Inc (NAGE) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic ...
Tuesday, November 04, 2025 09:17 PM
Niagen Bioscience Inc (NAGE) reports a 33% revenue increase and forms a new strategic partnership, despite challenges from FDA decisions on NMN.
NAD historical stock data
date open high low close volume
14/11/25 11.96 11.98 11.91 11.97 497,900
13/11/25 12.06 12.06 12.00 12.03 584,332
12/11/25 12.14 12.16 12.00 12.06 772,800
11/11/25 11.98 12.11 11.96 12.09 891,000
10/11/25 11.85 11.98 11.83 11.98 793,000
07/11/25 11.87 11.88 11.79 11.81 1,036,900
06/11/25 11.99 12.00 11.89 11.91 725,143
05/11/25 11.98 12.00 11.93 11.96 678,400
04/11/25 12.00 12.015 11.95 11.96 972,592
03/11/25 12.01 12.03 11.92 11.97 843,000
Quote Details
52wk Low:10.40
52wk High:12.36
Vol:497.9K
Avg Vol(3m):13M
1Y Chng:-2.84%
1M Chng:+3.46%
Add to Watch List
More Information
Sector N/A
Index N/A
Market Cap. 2.99B